Cancer and Heart Failure in Scotland: Epidemiology, Interactions, and Prognostic Implications
Highlights
- Patients with an expanded definition of heart failure (HFexp) exhibit a modest but significant increase in cancer incidence, varying by cancer type.
- Coexistence of cancer and heart failure markedly worsens prognosis, with similar contributions from cardiovascular and cancer-related mortality.
- Cardio-oncology evidence emphasizes the importance of early cardiac monitoring and vigilant management in cancer survivors and patients undergoing cardiotoxic therapies.
- Emerging therapeutic and prophylactic strategies, including antihypertensive agents and novel heart failure treatments, show potential to mitigate cardiotoxicity and improve outcomes.
Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.